Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy

MedGenMed Medscape General Medicine

Volumn 7, Issue 2, 2005, Pages

  Jones, Brian M ^a   Chiu, Susan S S ^a   Wong, Wilfred H S ^a   Lim, Wilina W L ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INDINAVIR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MITOGENIC AGENT; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PHYTOHEMAGGLUTININ; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; MALE; PATIENT CARE; PATIENT MONITORING; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 25144434906     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mocroft A, Katlama C, Johnson AM, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22-29.
2. Anton PA, Mitsuyasu RT, Deeks SG, et al. Multiple measures of HIV burden in blood and tissues are correlated with each other but not with clinical parameters in aviremic subjects. AIDS. 2003;17:53-63.
3. Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resist Updat. 2002;5:219-223.
4. Anthony KB, Yoder C, Metcalf JA, et al. Incomplete T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J AIDS. 2003;33:125-133.
5. Yoshioka M, Bradley WG, Shapshak P, et al. Role of immune activation and cytokine expression in HIV-1 associated neurological disease. Adv Neuroimmunol. 1995;5:335-358.
6. Osborn L, Kunkel S, Nabel GJ. Tumour necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Nat Acad Sci U S A. 1989;86:2336-2340.
7. Schnittman SM, Singer KH, Greenhouse JJ, et al. Thymic microenvironment induces HIV expression: physiological secretion of IL-6 by thymic epithelial cells up-regulated virus infection in chronically infected cells. J Immunol. 1991;147:2553-2558.
8. Amadori A, Zamaradi R, Veronese ML, et al. B-cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol. 1991;146:57-62.
9. Martinez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol. 2002;14:528-532.
10. Weimer R, Zipperle S, Daniel V, et al. HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B-cell help and autoantibody formation against CD4 cells. Clin Exp Immunol. 1998;111:20-29.
11. Marone G, Florio G, Petraroli A, dePaulis A. Dysregulation of the IgE/Fc epsilon RI network in HIV-1 infection. J Allergy Clin Immunol. 2001;107:22-30.
12. Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell responses against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A. 1995;92:11135-11139.
13. Bogner JR, Walli R, Goebel FD. Th1/Th2 shift in HIV lymph nodes: no contribution of CD60 cells. Infection. 2001;29:32-36.
14. Hu R, Oyaizu N, Kalyanaraman VS, Pahwa S. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine responses: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin Immunol Immunopathol. 1994;73:245-251.
15. Hyjek E, Lischner HW, Hyslop T, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol. 1995;155:4060-4071.
16. Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 1997;11:1111-1118.
17. Romagnani S, Maggi E, Del Prete G. Alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res Hum Retroviruses. 1994;10:iii-ix.
18. Chiu SS, Lau YL. Perinatally acquired human immunodeficiency virus infection in children in Hong Kong: the experience of one centre. HK J Paediatr (new series). 2000;5:132-138.
19. Lee BW, Yap HK, Chew FT, et al. Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry. 1996;26:8-15.
20. Czerkinsky C, Nilsson LA, Nygren H, et al. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;65:109-112.
21. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;65:301-309
22. Jones BM, Liu TF, Wong RWS. Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity. 1999;31:117-124.
23. Jones BM, Kwok CCH, Kung AWC. Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL10 and tumour necrosis factor-alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metabol. 1999; 84:4106-4110.
24. Jones BM, Kwok JSY, Kung AWC. Changes in cytokine production during pregnancy in patients with Graves' disease. Thyroid. 2000;10:701-707.
25. Jones BM. Changes in cytokine production in healthy subjects practicing Guolin Qigong: a pilot study. BMC Complement Altern Med. 2001;1:8. Available at: http://www.biomedcentral.com/1472-6882/1/8 Accessed April 19, 2005.
26. Jones BM, Ma ESK, Peiris JSM, et al. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp Immunol. 2004;135:467-473.
27. Natarajan V, Lempicki RA, Sereti I, et al. Increased peripheral expansion of naïve CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc Natl Acad Sci U S A. 2002;99:10712-10717.
28. Stylianou E, Aukrust P, Kvale D, et al. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression -- down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol. 1999;116:115-120.
29. Brazille P, Dereuddre-Bosquet N, Leport C, et al. Decrease in plasma TNF-a level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. Clin Exp Immunol. 2003;13:304-311.
30. Aukrust P, Muller F, Lien E, et al. Tumour necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active anti-retroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis. 1999;179:74-82.
31. Reuben JM, Lee BN, Paul M, et al. Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression. J Allergy Clin Immunol. 2002;110:255-261.
32. Resino S, Correa R, Bellon JM, Munoz-Fernandez MA. Preserved immune system in long-term asymptomatic vertically HIV-1 infected children. Clin Exp Immunol. 2003;132:105-112.
33. Goletti D, Kinter AL, Coccia EM, et al. Interleukin (IL)-4 inhibits phorbol ester-induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta and IL1 receptor cantagonist. Cytokine. 2002;17:28-35.